Benchmark sees sluggish end-user markets, cuts Harvard Bioscience shares target
On Friday, Benchmark lowered its price target on Harvard Bioscience Inc. (NASDAQ:) shares to $5.50...
On Friday, Benchmark lowered its price target on Harvard Bioscience Inc. (NASDAQ:) shares to $5.50...
By Kevin Buckland and Sruthi Shankar TOKYO (Reuters) -The dollar was close to a one-week...
On Friday, Baird raised the price target for Curtiss-Wright (NYSE:) shares to $312 from $300,...
On Friday, Needham raised its rating on shares of Doximity Inc (NYSE:) to Buy, citing...
On Friday, Baird raised the price target for CyberArk Software (NASDAQ:) shares to $315 from...
Diodes Incorporated (NASDAQ:), a leading global manufacturer and supplier of high-quality application-specific standard products within...
Chelsea are set to add an eighth goalkeeper to their squad as they agree a £17m fee with Genk for Mike Penders.
Turkish silver medal-winning shooter Yusuf Dikec says "storms were raging inside", despite going viral for his calm and casual demeanour.
Celtic captain Callum McGregor announces his retirement from international football with Scotland.